PENTACEL
Google image searchProduct monograph
Active ingredients
pertussis toxoid, 20 MCG/0.5 ML
filamentous haemagglutinin, 20 MCG/0.5 ML
fimbriae, 5 MCG/0.5 ML
pertactin, 3 MCG/0.5 ML
diphtheria toxoid, 15 LF/0.5 ML
tetanus toxoid, 5 LF/0.5 ML
poliovirus type 1 mahoney (inactivated), 29 UNIT/0.5 ML
poliovirus type 2 mef1 (inactivated), 7 UNIT/0.5 ML
poliovirus type 3 saukett (inactivated), 26 UNIT/0.5 ML
haemophilus influenzae type b-prp, 10 MCG/0.5 ML
tetanus protein, 30 MCG/0.5 ML
DIN: 02534797
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: SANOFI PASTEUR LIMITED
Date: 06-MAY-2024
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07C — BACTERIAL AND VIRAL VACCINES, COMBINED (ATC, ATC/DDD)
- J07CA — Bacterial and viral vaccines, combined (ATC, ATC/DDD)
- J07CA06 — DIPHT-HEMOPH INFLUEN B-PERTUSS-POLIO-TETANUS (ATC/DDD)
Reference brand drug: Pediacel, Pentacel
External Links for Pentacel
Search on Google
- Pentacel side effects
- Pentacel dosage
- pertussis toxoid side effects
- pertussis toxoid dosage
- filamentous haemagglutinin side effects
- filamentous haemagglutinin dosage
- fimbriae side effects
- fimbriae dosage
- pertactin side effects
- pertactin dosage
- diphtheria toxoid side effects
- diphtheria toxoid dosage
- tetanus toxoid side effects
- tetanus toxoid dosage
- poliovirus type 1 mahoney side effects
- poliovirus type 1 mahoney dosage
- poliovirus type 2 mef1 side effects
- poliovirus type 2 mef1 dosage
- poliovirus type 3 saukett side effects
- poliovirus type 3 saukett dosage
- haemophilus influenzae type b-prp side effects
- haemophilus influenzae type b-prp dosage
- tetanus protein side effects
- tetanus protein dosage
